Fulcrum herds oversubscribed $13.2M round for KC cattle tech startup with KCRise Fund, iiM in the corral
September 28, 2021 | Startland News Staff
A Kansas City-based precision livestock company will use its fresh Series A funding harvest to accelerate genetic progress and sustainably deliver more protein with fewer inputs, its top executive announced Tuesday.
“Our mission is clear, and we are grateful for the support of our investors who join us on our journey to ensure meat and milk are viable food choices for future generations,” said Kerryann Kocher, CEO of Vytelle.
The cattle tech startup announced Tuesday an oversubscribed funding round worth $13.2 million — co-led by Overland Park-based Ag-tech venture-based Fulcrum Global Capital and the private equity firm Open Prairie, through the Open Prairie Rural Opportunities Fund. The financing also included participation from Kansas City’s KCRise Fund II and Innovation In Motion, Illinois-based Serra Ventures, and existing investor UK-based Wheatsheaf Group.
Vytelle’s platform — combining a breakthrough in vitro fertilization (IVF) technology, an animal performance data capture system, and an artificial intelligence based genetic analytics engine — provides progressive cattle producers the technology to multiply the impact of elite livestock productivity and profitability. It’s seen rapid growth since its launch in 2020, currently serving cattle producers in 21 countries.
Click here to learn more about Vytelle.
“Vytelle’s ability to scale globally is a game changer for the cattle industry to produce a more efficient and sustainable global cattle herd,” explained Duane Cantrell, CEO of Fulcrum Global Capital — a firm especially interested in companies with technologies and approaches which increases yields, reduces food waste, and/or makes food safer and more transparent.
Click here to explore Fulcrum’s other portfolio companies.
The funding reflects Vytelle’s aggressive expansion strategy, which includes propelling the platform’s IVF offering to strategic markets worldwide and investment in new ways to create more predictable genetic selections for global cattle operations, the company said.
“We’ve been searching for another agtech investment in the KC region with a large addressable market, proven traction, seasoned agriculture investors and experienced team,” Darcy Howe, founder and managing director of KCRise Fund. “Kerryann and her team, board and investors exceed every measure and we are excited that our KC-based investors will be a part of this global/local growth story.”
Click here to learn more about KCRise Fund’s portfolio.
This story is possible thanks to support from the Ewing Marion Kauffman Foundation, a private, nonpartisan foundation that works together with communities in education and entrepreneurship to create uncommon solutions and empower people to shape their futures and be successful.
For more information, visit www.kauffman.org and connect at www.twitter.com/kauffmanfdn and www.facebook.com/kauffmanfdn
Featured Business

2021 Startups to Watch
stats here
Related Posts on Startland News
Fortune 500 company says it’s bringing 2,000 jobs paying $100K to OP’s former Sprint campus
No better proof that ‘Kansas City has the capacity and competitiveness to meet this moment’ A globe-spanning fintech leader’s plan to create a new strategic hub in Overland Park is expected to include a $4 billion payroll investment in the Kansas City region over the next decade, the company said this week. Milwaukee-based Fiserv officially…
Mr K finalist reveal: Meet the 10 contenders for KC Chamber’s Small Business of the Year
The KC Chamber just announced the 10 finalists for its prestigious 2025 Small Business of the Year honor — setting the stage for a two-month campaign for selected entrepreneurs that ends this summer with one company crowned the Mr. K Award winner. “Small businesses remain the driving force of Kansas City’s economy, and we couldn’t…
USDA approves KC biotech startup’s secret weapon in the fight against cancer in dogs
Full USDA approval of a Kansas City startup’s bone cancer therapy for dogs reflects a more-than-decade-long commitment to improving the lives of pets and their families, said Tammie Wahaus, CEO of ELIAS Animal Health. The U.S. Department of Agriculture Center for Veterinary Biologics recently approved the first-in-class ELIAS Cancer Immunotherapy (ECI) treatment for canine osteosarcoma…



